A high pan-immune-inflammation value before chemoradiotherapy indicates poor outcomes in patients with small-cell lung cancer

Kucuk, A; Topkan, E; Ozkan, EE; Ozturk, D; Pehlivan, B; Selek, U

Topkan, E (通讯作者),Baskent Univ, Med Fac, Dept Radiat Oncol, Kazim Karabekir St, TR-01120 Adana, Turkiye.

INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2023; 37 ():

Abstract

Objectives: The objective of our study was to assess the prognostic significance of the Pan-Immune-Inflammation Value (PIV) before concurrent chemorad......

Full Text Link